9-10 September 2021
Lipid Mediators in Brain Diseases Symposium, Hasselt, Belgium
Professor Dalli presenting Specialised pro-resolving mediators as modulators of innate and adaptive immunity
25 June 2021
ICBL Webinar – Lipid Mediators in Inflammation
Professor Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
22 November 2019
The London Metabolomics Network Autumn meeting
Professor Jesmond Dalli presenting Establishing a role for immunoresolvents in the maintenance of homeostasis and as diagnostic markers in patient stratification
20 – 23 October 2019
Bioactive Lipids in Cancer, Inflammation and Related Diseases 16th International Conference, St. Petersburg, Florida
- Professor Jesmond Dalli presenting Insights mechanisms elicited by immunoresolvants in the maintenance of homeostasis and the termination of inflammation, Tuesday 22 October
- Dr Romain Colas presenting Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis, Monday 21 October
- Mr Issa Beegun presenting Maresin 1 regulates peripheral leukocyte responses in patients with chronic eosinophilic nasal polyposis, Monday 21 October
- Ms Roberta De Matteis presenting Pro-resolving mediators mediate the protective actions of aspirin in colitis associated colorectal cancer, Monday 21 October
- Dr Patricia Soares De Souza presenting Enriched marine oil supplements increase peripheral blood SPM concentrations and reprogram host immune responses: A randomized double-blind placebo-controlled study, Monday 21 October
- Mr Esteban Gomez Cifuentes presenting Identification of pro-resolving mediators-based predictive biomarkers to DMARD responsiveness in rheumatoid arthritis, Monday 21 October
- Dr Duco Koenis presenting RvD5n-3 DPA engages GPR101 to promote the resolution of inflammatory arthritis and Escherichia coli infections, Tuesday 22 October
- Dr Lucy Ly presenting MCTR1, MCTR2, and MCTR3 resolve inflammation and protect joints in Inflammatory Arthritis, Monday 21 October
30 September – 2 October 2019
15th GERLI international Lipidomics meeting, Compiègne, France
16 October 2019
William Harvey Day, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Dr Romain Colas poster presentation, Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis
William Harvey Research Institute Annual Review 2019, 12 June 2019
The importance of LipoQuality in biological systems, Professor Makoto Arita, visiting Professor
Joint Meeting of NC-IUPHAR and the British Pharmacological Society, Paris, France , 26 – 28 April 2019
Banff Inflammation Workshop, Banff, Alberta, Canada, 24-27 January 2019
Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotctive and mediate the actions of statins in controlling inflammation
Dr Romain Colas presenting Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
Dr Patricia Soares De Souza poster presentation of 13-Series Resolvins Mediate the Leukocyte-Platelet Actions of Atorvastatin and Pravastatin in Inflammatory Arthritis
Ms Mary Walker poster presentation of RvT4 Reduces Joint Oedema and Atherosclerosis during Inflammatory Arthritis
The British Pharmacological Society Pharmacology 2018, London, 18-20 December 2018
Dr Patricia Soares De Souza poster presentation of Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease – 18 December, 2018, 2PM
7th European Workshop on Lipid Mediators, Brussels, 12-14 September 2018
Dr Jesmond Dalli, giving two presentations: Profiling the resolution metabolome: considerations and methodologies and Functional Lipid Mediator Profiling in Establishing Disease Etiopathogenesis
Dr Patricia Soares De Souza presenting the poster Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
Ms Kim Pistorius presenting at the Young Investigator Session PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function
Ms Mary Walker presenting at the Young Investigator Session 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
Pharmacology 2017, London, 11-13 December
Ms Kim Pistorius presenting PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function
Ms Mary Walker presenting 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
Bioactive Lipids in Cancer, Inflammation and Related Diseases, Puerto Vallarta, Mexico, 22-25 October 2017
Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotective and mediate the actions of statins in controlling inflammation
UK Life Science and Medicine Summit, Beijing, September 2017
Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?
Eurpoean Shock Society, Paris, September 2017
Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?
World Congress on Inflammation, Solna, June 2017
Dr Jesmond Dalli, Immunoresolvants are regulated by the brain and control host responses to infections and tissue regeneration
Meeting of the Minds, Royal Society, London, May 2017
Dr Jesmond Dalli, ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control
Biochemical Society, Birmingham, January 2017
Dr Jesmond Dalli, Maresin conjugates in tissue regeneration promote the clearance of bacterial infections and are organ protective
BSI 2016, Liverpool, December 2016
Dr Jesmond Dalli, ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control
Physiology 2016, Dublin, July 2016
Dr Jesmond Dalli and Dr C.N. Serhan, Elucidation of Thirteen Series Resolvins that Regulate Host Responses in Infections
William Harvey Research Institute 30th Anniversary, June 2016
LBMSDG, London, June 2016
Dr Jesmond Dalli, LC-MS/MS Based Structure Elucidation Of Novel Bioactive Mediators And Functional Lipid Mediator Profiling
BSI London Immunology Showcase, May 2016
Dr Jesmond Dalli, Omega-3-fatty acids in inflammatory resolution and organ protection: Specialized Pro-resolving Mediators
OARSI, Amsterdam, April 2016
Dr Jesmond Dalli, Lipid Mediators and the Resolution of Chronic Inflammation: Implications for Arthritis Therapy
JDALLILAB 